DP
PGEN icon

Diadema Partners’s Precigen PGEN Stock Holding History

Diadema Partners’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$771K Buy
135,293
+80,000
+145% +$346K 0.1% 110
2026
Q1 		$214K Buy
+55,293
New +$227K 0.04% 124

Other funds holding PGEN

PCM
Patient Capital Management Baltimore, Maryland $3.05B AUM 42.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Diadema Partners's PGEN Position: Q2 2026 in Review

Diadema Partners increased its Precigen (PGEN) stake by 145% in Q2 2026, buying an estimated $346K and bringing the position to 135,293 shares worth $771K. The position accounts for 0.1% of the portfolio, ranked #110.

Diadema Partners first reported a position in PGEN in Q1 2026 and has held it in 2 quarters since. 211 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

  • Diadema Partners held 135,293 shares of Precigen worth $771K as of Q2 2026.
  • Diadema Partners bought 80,000 Precigen shares in Q2 2026, an estimated $346K.
  • Precigen made up 0.1% of Diadema Partners's portfolio in Q2 2026, its #110 holding.
  • Diadema Partners first reported a position in Precigen in Q1 2026 and has held it in 2 quarters since.
  • 211 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on Diadema Partners's 13F filing for Q2 2026, filed 14 Aug 2026.